ArticleBMC pregnancy and childbirth2026
Establishing trimester-specific reference intervals for coagulation parameters in pregnant women in China.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuring pregnancy, the body's hemorrhagic and coagulation system undergoes significant changes. Reference intervals for coagulation parameters may vary across different study populations and with different testing instruments. This study aimed to establish reference intervals for coagulation parameters in non-pregnant and pregnant women in China.
methodsBetween January 2023 and February 2024, blood samples from 879 pregnant women and 253 healthy non-pregnant women were tested. The parameters tested included activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), fibrinogen (FBG), D-dimer, fibrin/fibrinogen degradation products (FDP), Plasminogen (PLG), thrombin-antithrombin complex (TAT), thrombomodulin (TM), plasmin-α2 plasmin inhibitor complex (PIC), and tissue plasminogen activator/plasminogen activator inhibitor-I complex (t-PAIC). Reference intervals were established using a non-parametric method.
resultsThe values of PT, INR, APTT, and TT decreased, while the concentrations of fibrinogen, D-dimer, FDP, PLG, TM, TAT, PIC, and t-PAIC increased significantly with advancing gestational age. Distinct reference intervals were established for healthy non-pregnant women and for women in the first, second, and third trimesters of pregnancy. Most intervals differed significantly across these groups.
conclusionsReference intervals for non-pregnant women and pregnant women in different trimesters vary. Description of the reference intervals according to trimester of pregnant women in China will help clinicians recognise abnormality and inform medical decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.